(Nasdaq:GCTK) believes it can tap into a diabetes market that includes millions of people who aren't being served completely.

Dexcom's Stelo is an over-the-counter continuous glucose monitor that leverages AI-driven insights to help you track, evaluate, and manage your metabolic health.